copy number variant detection increases diagnostic yield ... · pajusalu et al - poster - eshg_2018...

1
Copy number variant detection increases diagnostic yield of Mendeliome sequencing S ander Pajusalu 1,2 , Hanno Roomere 1 , Tiina Kahre 1,2 , Ülle Murumets 1 , Villem Pata 1 , Katrin Õunap 1,2 1. Department of Clinical Genetics, United Laboratories, Tartu University Hospital, Tartu, Estonia 2. Department of Clinical Genetics, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia INTRODUCTION: Although complicated by the fragmented nature of the next-generation targeted resequencing data, copy number variants (CNVs) may be detected by read-depth analysis. Along with whole exome sequencing, sequencing of large panels of disease-associated genes (Mendeliomes) are widely used in clinical practice. The diagnostic utility of CNV detection from Mendeliome sequencing, however, remains underreported. AIM: To investigate the clinical utility of copy number detection from Mendeliome sequencing data. CONCLUSION: CNV detection improved diagnostic yield of Mendeliome sequencing by over 1% without increasing costs significantly, and thus should be encouraged in all clinical laboratories. ACKNOWLEDGMENTS: This work was supported by Estonian Research Council PUT355, University of Tartu baseline funding and Estonian Society of Medical Genetics. 1407 patients sequenced by TruSight One panels (Illumina Inc.) targeting 4813 genes. In addition to regular small-variant analysis CNVs were called using CoNIFER software Validation of CNVs using appropriate methods Analysis of clinical utility and increased diagnostic yield. METHODS: RESULTS: Among 1407 patients conclusive genetic diagnosis was made after Mendeliome sequencing in 327 (23.2%), accompanied by additional 10.8% patients in whom variants of unclear clinical significance were reported. Rare CNVs were reported for 30 patients. The detected CNVs ranged from single exon to contiguous gene deletions. In additional two cases, X-chromosome aneuploidies were suspected after noticing variant read ratio discrepancies. In 18 (1.3%) patients, the CNVs were classified as disease causing, while others remained of unclear significance. In 4/18 cases, the CNV was identified in trans with pathogenic small variant. CONTACT: Sander Pajusalu [email protected] EXAMPLES: A heterozygous deletion of exons 22-24 in USH2A gene. On the second allele heterozygous pathogenic missense mutation was detected. 1) 2) 3) A distal duplication of chromosome 14, later confirmed to be due to a pathogenic ring chromosome 14. A partial deletion of CREBBP gene (appr. 24kb) causing Rubinstein-Taybi syndrome. Previous chromosomal microarray testing did not reveal this deletion. Authors declare no conflicts of interest.

Upload: others

Post on 07-Jul-2020

2 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Copy number variant detection increases diagnostic yield ... · Pajusalu et al - Poster - ESHG_2018 Created Date: 6/12/2018 6:50:02 AM

Copy number variant detection increases diagnostic yield of Mendeliome sequencing

Sander Pajusalu1,2, Hanno Roomere1, Tiina Kahre1,2, Ülle Murumets1, Villem Pata1, Katrin Õunap1,2

1. Department of Clinical Genetics, United Laboratories, Tartu University Hospital, Tartu, Estonia2. Department of Clinical Genetics, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia

INTRODUCTION: Although complicated by the fragmented nature of the next-generation targeted resequencing data, copy number variants (CNVs) may be detected by read-depth analysis. Along with whole exome sequencing, sequencing of large panels of disease-associated genes (Mendeliomes) are widely used in clinical practice. The diagnostic utility of CNV detection from Mendeliome sequencing, however, remains underreported.

AIM: To investigate the clinical utility of copy numberdetection from Mendeliome sequencing data.

CONCLUSION:• CNV detection improved diagnostic yield of

Mendeliome sequencing by over 1% withoutincreasing costs significantly, and thus should beencouraged in all clinical laboratories.

ACKNOWLEDGMENTS: This work was supportedby Estonian Research Council PUT355,University of Tartu baseline funding andEstonian Society of Medical Genetics.

1407 patients sequenced by TruSightOne panels (Illumina Inc.) targeting 4813 genes.

In addition to regular small-variant analysis CNVs were called using CoNIFER software

Validation of CNVs using appropriate methods

Analysis of clinical utility and increased diagnostic yield.

METHODS:

RESULTS:• Among 1407 patients conclusive genetic diagnosis was made after Mendeliome sequencing in

327 (23.2%), accompanied by additional 10.8% patients in whom variants of unclear clinicalsignificance were reported.

• Rare CNVs were reported for 30 patients.• The detected CNVs ranged from single exon to contiguous gene deletions.• In additional two cases, X-chromosome aneuploidies were suspected after noticing

variant read ratio discrepancies.• In 18 (1.3%) patients, the CNVs were classified as disease causing, while others remained of

unclear significance.• In 4/18 cases, the CNV was identified in trans with pathogenic small variant.

CONTACT: Sander [email protected]

EXAMPLES:

A heterozygous deletion of exons 22-24 in USH2A gene. On the second allele heterozygous pathogenic missense mutation was detected.

1) 2) 3)

A distal duplication of chromosome 14, later confirmed to be due to a pathogenic ring chromosome 14.

A partial deletion of CREBBP gene (appr. 24kb) causing Rubinstein-Taybi syndrome. Previous chromosomalmicroarray testing did not reveal this deletion.

Authors declare no conflicts of interest.